ROHTO PHARMACEUTICAL CO revenue for the last year amounted to 238.66 B JPY, the most of which — 156.66 B JPY — came from its highest performing source at the moment, Skin Care, the year earlier bringing 124.06 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought ROHTO PHARMACEUTICAL CO 136.67 B JPY, and the year before that — 121.42 B JPY.